セッション情報

FACO International Workshop

第53回・2015年・京都
FACO International Workshop
FACO International Workshop 4
Hepatic and Pancreatic Cancer 1: Translational Research
開催回
第53回・2015年・京都

Risk factors, clinical features, and prognosis after hepatectomy for centrally located hepatocellular carcinoma

演題番号 : FWS4-1

Fei Tian:1、Jianxiong Wu:1

1:Abdominal Department, Peking Union Medical College,Cancer Hospital

Risk factors, clinical features, and prognosis after hepatectomy for centrally located hepatocellular carcinoma

c-Met expression in HCC is a dominant target in TACE treatment

演題番号 : FWS4-2

Yamada Daisaku:1、Eguchi Hidetoshi:1、Wada Hiroshi:1、Kajihara Jun:1、Asaoka Tadafumi:1、Noda Takehiro:1、Goto Kunihito:1、Tomimaru Yoshito:2、Doki Yuichiro:1、Mori Masaki:1

1:Gastroenterological surgery, Graduate School of Medicine, Osaka University、2:Department of surgery, Toyonaka Municipal Hospital

c-Met expression in HCC is a dominant target in TACE treatment

Elevated levels of mRNAs encoding dihydropyrimidine dehydrogenase and thymidylate synthetase are associated with improved survival of patients with hepatocellular carcinoma treated with S-1

演題番号 : FWS4-3

Kuramochi Hidekazu:1,2、Okano Yusuke:3、Nakajima Go:2、Katagiri Satoshi:1,3、Ariizumi Shunichi:3、Hayashi Kazuhiko:2,3、Araida Tatsuo:1、Yamamoto Masakazu:3

1:Dept of Gastrointestinal Surgery, Yachiyo Medical Center, Tokyo Women's Medical University、2:Dept. of Chemotherapy and Palliative Care, Tokyo Women's Medical University、3:Dept of Gastrointestinal Surgery, Tokyo Women's Medical University

Elevated levels of mRNAs encoding dihydropyrimidine dehydrogenase and thymidylate synthetase are associated with improved survival of patients with hepatocellular carcinoma treated with S-1

Circulating tumor cells early predict prognosis of hepatocellular carcinoma treated with transarterial chemoembolization: A prospective study

演題番号 : FWS4-4

Zhou Bo:1、Yang Guowei:1、Wang Jianhua:1、Liu Rong:1

1:Intervention Oncology, Intervention Radiology, Fudan University Zhongshan Hospital

Circulating tumor cells early predict prognosis of hepatocellular carcinoma treated with transarterial chemoembolization: A prospective study

Ginsenoside Rg3 improves transarterial chemoembolization treatment in chinese patients with advanced hepatocellular carcinoma

演題番号 : FWS4-5

Zhou Bo:1、Wang Jianhua:1、Yan Zhiping:1

1:Intervention Oncology, Intervention Radiology, Fudan University Zhongshan Hospital

Ginsenoside Rg3 improves transarterial chemoembolization treatment in chinese patients with advanced hepatocellular carcinoma